Viragen Inc said start expanded study alpha interferon topical ointment treatment genital herpes .
It said conduct phase III study two different dosage form treatment compare placebo , nonmedicated substitute , least 154 men woman .
Viragen said study result expected October 1987 .
Viragen said prepared submit license application ointment England , Canada , West Germany , addition U.S. , phase III study completed .
Reuter & # 3 ; 